A 38-year-old woman with a known BRCA1 mutation attends the GP to discuss risk-reducing options. She has completed her family. According to NICE CG164...

Question

A 38-year-old woman with a known BRCA1 mutation attends the GP to discuss risk-reducing options. She has completed her family. According to NICE CG164, which is the single most effective risk-reducing intervention for ovarian cancer in BRCA1 carriers?

Accepted Answer

Risk-reducing bilateral salpingo-oophorectomy

Answer

Annual CA-125 screening

Answer

Annual transvaginal ultrasound

Answer

Oral contraceptive pill for 10 years

Answer

Risk-reducing mastectomy

uk-drcog MCQ (SBA): BRCA and Risk-Reducing Surgery

A 38-year-old woman with a known BRCA1 mutation attends the GP to discuss risk-reducing options. She has completed her family. According to NICE CG164, which is the single most effective risk-reducing intervention for ovarian cancer in BRCA1 carriers?